MYCN and neoplasm: Over the past two decades, the International Neuroblastoma Risk Group (INRG) classification system has defined a unified approach for pretreatment assessment, which includes age at diagnosis, histology, the grade of tumor differentiation, MYCN status, 11q aberration, and ploidy (3).